These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18260878)

  • 1. [Peculiarities of the course of myocardial infarction in young patients with essential arterial hypertension].
    Bazina IB; Alisina NA; Gavrilova OE
    Kardiologiia; 2007; 47(6):56-7. PubMed ID: 18260878
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of myocardial infarction: hypotensive effect of different thrombolytic agents.
    Puletti M; Staropoli P; Curione M; Matteoli S; Trappolini M; Coppola A
    Riv Eur Sci Med Farmacol; 1994; 16(5-6):113-8. PubMed ID: 7480969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The predictors of myocardial electrical instability after its infarction and thrombolytic therapy].
    Chernetsov VA
    Voen Med Zh; 2000 Mar; 321(3):27-31. PubMed ID: 10815535
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities of the use of ivabradine in complex therapy acute coronary syndrome].
    Tereshchenko SN; Kositsyna IV; Golubev AV
    Kardiologiia; 2008; 48(7):10-3. PubMed ID: 18789019
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
    Thune JJ; Signorovitch J; Kober L; Velazquez EJ; McMurray JJ; Califf RM; Maggioni AP; Rouleau JL; Howlett J; Zelenkofske S; Pfeffer MA; Solomon SD
    Hypertension; 2008 Jan; 51(1):48-54. PubMed ID: 18025296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of systemic arterial hypertension on mid-term survival of patients with acute myocardial infarction treated with fibrinolytic agents].
    Martínez Sande JL; González-Juanatey JR; García-Acuña JM; Amaro Cendón A; Fernández Vázquez F; Fernández López JA; García Seara J; Vega Fernández JM; López Lago A; Gil de la Peña M
    Med Clin (Barc); 1997 Oct; 109(14):532-7. PubMed ID: 9580043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).
    Ahmed N; Wahlgren N; Brainin M; Castillo J; Ford GA; Kaste M; Lees KR; Toni D;
    Stroke; 2009 Jul; 40(7):2442-9. PubMed ID: 19461022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic lidocaine use in acute myocardial infarction revisited in the thrombolytic era.
    Tan HL; Lie KI
    Am Heart J; 1999 May; 137(5):770-3. PubMed ID: 10220620
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis.
    Mehta RH; O'Shea JC; Stebbins AL; Granger CB; Armstrong PW; White HD; Topol EJ; Califf RM; Ohman EM
    J Am Coll Cardiol; 2011 Jan; 57(2):138-46. PubMed ID: 21211684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial snapshot electrocardiograms and continuous 12-lead ST-segment electrocardiographic monitoring for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction.
    Foussas SG; Zairis MN; Tsiaousis GZ; Georgilas AT; Patsourakos NG; Kontos CF; Prodromitou M; Batika PC; Mytas DZ; Adamopoulou EN; Handanis SM; Argyrakis SK
    Int J Cardiol; 2010 Sep; 144(1):169-70. PubMed ID: 19178963
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antihypertensive and antiischemic effectiveness and safety of the AT1-receptor blocker irbesartranin arterial hypertension in patients with prior myocardial infarction].
    Tepliakov AT; Stepacheva TA; Ivannikova OA; Pushnikova EIu; Kaliuzhin VV; Malakhovich EV; Makushkin EV; Zenevich MV
    Klin Med (Mosk); 2004; 82(12):43-9. PubMed ID: 15732720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The characteristics of thrombolytic therapy in myocardial infarct in middle-aged and elderly patients].
    Teslia AN; Kolesnikov SA; Mikhaĭlov AA
    Voen Med Zh; 1999 Jul; 320(7):40-4. PubMed ID: 10484919
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic therapy for acute myocardial infarction in unsuspected infective endocarditis.
    Ortega-Carnicer J; Ruiz-Lorenzo F; Benedicto A
    Int J Cardiol; 2005 Aug; 103(1):108-10. PubMed ID: 16061133
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    Clin Exp Hypertens; 2010; 32(8):491-8. PubMed ID: 21091365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly patients should not be denied fibrinolytic therapy.
    Wong CK; White HD
    Nat Clin Pract Cardiovasc Med; 2007 Oct; 4(10):520-1. PubMed ID: 17724481
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of fasting blood glucose, diabetes treatment, blood pressure and anti-hypertension treatment on cardiovascular disease incidence: a 30-year follow-up study of 740 incident patients with Type 2 diabetes.
    Jansson SP; Andersson DK; Svärdsudd K
    Diabet Med; 2013 Mar; 30(3):349-57. PubMed ID: 23278364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).
    Tan NS; Goodman SG; Cantor WJ; Tan MK; Yan RT; Bagnall AJ; Mehta SR; Fitchett D; Strauss BH; Yan AT;
    Am J Cardiol; 2014 Oct; 114(7):955-61. PubMed ID: 25118119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of thrombolytic therapy on QT dispersion in acute myocardial infarction and its role in the prediction of reperfusion arrhythmias.
    Ornek E; Duran M; Ornek D; Demirçelik BM; Murat S; Kurtul A; Çiçekçioğlu H; Çetin M; Kahveci K; Doger C; Çetin Z
    Niger J Clin Pract; 2014; 17(2):183-7. PubMed ID: 24553029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.